Exploiting the untapped proteome using bullvalene-based cyclic peptides for drug discovery. The shapeshifting properties of bullvalene overcome the limitations of current compound libraries to create novel cyclic peptides with poly-pharmacology.
Principal Investigator: Michael Stowell
Industry: Therapeutics